Nisa Investment Advisors LLC Raises Holdings in Express Scripts Holding (ESRX)

Nisa Investment Advisors LLC raised its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 8.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 233,538 shares of the company’s stock after purchasing an additional 17,441 shares during the period. Nisa Investment Advisors LLC’s holdings in Express Scripts were worth $17,431,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Burt Wealth Advisors lifted its stake in shares of Express Scripts by 11.4% in the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares during the last quarter. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts in the 3rd quarter valued at $120,000. Monroe Bank & Trust MI lifted its stake in shares of Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares during the last quarter. Capstone Investment Advisors Netherlands B.V. lifted its stake in shares of Express Scripts by 49.3% in the 2nd quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock valued at $179,000 after purchasing an additional 924 shares during the last quarter. Finally, Nelson Roberts Investment Advisors LLC acquired a new stake in shares of Express Scripts in the 3rd quarter valued at $193,000. 88.28% of the stock is owned by institutional investors.

Several equities research analysts recently issued reports on ESRX shares. SunTrust Banks reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Express Scripts in a research note on Friday. Robert W. Baird raised shares of Express Scripts from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $72.00 to $81.00 in a research note on Friday, December 15th. Raymond James Financial reaffirmed a “sell” rating on shares of Express Scripts in a research note on Friday, December 15th. Needham & Company LLC reaffirmed a “hold” rating on shares of Express Scripts in a research note on Thursday, December 21st. Finally, Mizuho set a $67.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a research note on Tuesday, October 24th. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. Express Scripts presently has an average rating of “Hold” and an average price target of $77.09.

In other news, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the transaction, the vice president now owns 87,400 shares in the company, valued at approximately $6,124,992. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,644 shares of company stock worth $1,289,609. Insiders own 0.68% of the company’s stock.

Express Scripts Holding (ESRX) opened at $80.87 on Friday. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $81.75. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The stock has a market cap of $45,360.00, a PE ratio of 13.43, a PEG ratio of 0.89 and a beta of 0.87.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the previous year, the firm posted $1.74 EPS. The business’s revenue was down 2.9% compared to the same quarter last year. equities research analysts forecast that Express Scripts Holding will post 7.04 earnings per share for the current year.

Express Scripts announced that its board has authorized a share buyback plan on Monday, December 18th that allows the company to repurchase 45,000,000 outstanding shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/13/nisa-investment-advisors-llc-raises-holdings-in-express-scripts-holding-esrx.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit